• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

W.L. Gore officials think they can spur insulin delivery system innovation

December 6, 2019 By Chris Newmarker

W.L. Gore PhysioLogic DevicesW.L. Gore announced this week that it is investing in PhysioLogic Devices, a startup developing an implantable intraperitoneal insulin delivery system.

The size of the investment was not disclosed. But it was part of Gore’s Micro-Equity Investment (MEI) program, which provides investments of up to $500,000.

W.L. Gore officials think the company’s more than 60 years in material science competence will help them solve a major technological challenge that implantable insulin delivery systems face: intraperitoneal catheter obstruction.

“Overcoming catheter obstructions plays an important role in the development of intraperitoneal insulin delivery systems,” PhysioLogic CEO Greg Peterson said in a news release.

“We look forward to the opportunity to collaborate with Gore to solve this technical challenge based on Gore’s material science capability and develop a system that offers our life-changing treatment to millions of individuals living with insulin-requiring diabetes,” Peterson said.

On top of collaborating on overcoming catheter obstruction challenges, Gore’s investment will help PhysioLogic tackle hurdles related to implantable micropumps and actuators and support the startup’s development goals for the upcoming years.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: PhysioLogic Devices, W.L. Gore

IN CASE YOU MISSED IT

  • FDA approves first targeted infusion therapy for HER2-low breast cancer
  • Abbott, WeightWatchers partner on diabetes care
  • Insulet up on Q2 sales beat, raised full-year guidance
  • Aptar acquires Orbital dry powder inhaler license
  • Tandem sinks on Q2 misses, slashed sales guidance

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS